Nuveen
OBIO icon

Nuveen’s Orchestra BioMed OBIO Stock Holding History

Nuveen’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Buy
+52,118
New +$213K ﹤0.01% 3600
2025
Q2 		– Sell
-41,729
Closed -$179K – 3366
2025
Q1 		$179K Hold
41,729
– – ﹤0.01% 3146
2024
Q4 		$167K Hold
41,729
– – ﹤0.01% 3231
2024
Q3 		$214K Hold
41,729
– – ﹤0.01% 3210
2024
Q2 		$340K Buy
41,729
+19,433
+87% +$113K ﹤0.01% 3117
2024
Q1 		$118K Buy
22,296
+10,290
+86% +$69.7K ﹤0.01% 3240
2023
Q4 		$110K Buy
+12,006
New +$82K ﹤0.01% 3278

Other funds holding OBIO

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Nuveen's OBIO Position: Q2 2026 in Review

Nuveen opened a new position in Orchestra BioMed (OBIO) in Q2 2026: 52,118 shares worth $225K. The stake represents ﹤0.01% of the portfolio and ranks #3600 among its holdings. This is a return to the name: Nuveen previously reported a position in OBIO as recently as Q1 2025.

Nuveen first reported a position in OBIO in Q4 2023 and has held it in 7 quarters since. The position peaked at $340K in Q2 2024. 77 funds tracked by Wall St. Rank hold OBIO as of Q2 2026.

  • Nuveen held 52,118 shares of Orchestra BioMed worth $225K as of Q2 2026.
  • Orchestra BioMed was a new Nuveen position in Q2 2026.
  • Orchestra BioMed made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3600 holding.
  • Nuveen first reported a position in Orchestra BioMed in Q4 2023 and has held it in 7 quarters since.
  • Nuveen's Orchestra BioMed position peaked at $340K in Q2 2024.
  • 77 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.